Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q3 2025 | -23.02% |
| Q2 2025 | 17.82% |
| Q1 2025 | -17.73% |
| Q4 2024 | 63.61% |
| Q3 2024 | 38.14% |
| Q2 2024 | 7.68% |
| Q1 2024 | 24.82% |
| Q4 2023 | 0.45% |
| Q3 2023 | 14.46% |
| Q2 2023 | -18.67% |
| Q1 2023 | 0.62% |
| Q4 2022 | 4.69% |
| Q3 2022 | 226.98% |
| Q2 2022 | 83.49% |
| Q1 2022 | 0.00% |